Previous 10 | Next 10 |
Rockwell Medical, Inc. (RMTI) Q2 2022 Earnings Conference Call August 15, 2022, 08:00 ET Company Participants Heather Hunter - SVP & Chief Affairs Officer Mark Strobeck - President, CEO & Director Russell Skibsted - EVP, CFO & Chief Business Officer ...
Rockwell Medical press release ( NASDAQ: RMTI ): Q2 GAAP EPS of -$0.56 beats by $0.25 . Revenue of $18.68M (+23.4% Y/Y) beats by $1.88M . As of June 30, 2022, Rockwell had cash and cash equivalents of $30.8 million and 9,407,296 shares outstanding and 9,056,377...
Revenue was $18.7 million for the second quarter 2022, a 16% increase over the first quarter 2022, representing the highest quarterly revenue to-date for Rockwell Gross profit was $1.7 million in the second quarter 2022 compared to gross loss of $786,000 in the...
Rockwell Medical ( NASDAQ: RMTI ) is scheduled to announce Q2 earnings results on Monday, August 15th, before market open. The consensus EPS Estimate is -$0.81 (-800.0% Y/Y) and the consensus Revenue Estimate is $16.8M (+11.0% Y/Y). Over the last 3 months, EPS estimate...
Rockwell Medical to Release Second Quarter 2022 Financial Results on Monday, August 15 PR Newswire WIXOM , Mich. , Aug. 3, 2022 /PRNewswire/ -- Rockwell Medical, Inc. (Nasdaq: RMTI), a commercial healthcare company focused on providing life-sustainin...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Gainers: ToughBuilt Industries ( TBLT ) +53% . Yoshitsu ( TKLF ) +39% . Hanger ( HNGR ) +25% . Eve Holding ( EVEX ) +21% . Community Health Systems ( CYH ) +19% . Tabula Rasa HealthCare ( TRHC ) +12% . Rockwell Me...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Rockwell Medical (NASDAQ:RMTI) on Wednesday said that the U.S. FDA had requested the company to perform a microbial challenge study for its planned phase 2 trial of its iron salt to treat iron deficiency in home infusion patients. A microbial challenge study is a standard study that eval...
Rockwell Medical Provides Corporate and Clinical Update PR Newswire - Closes $7.5 Million Second Tranche Investment from DaVita - $30 Million in Total Capital Raised This Quarter - Receives Additional Feedback from FDA on its IND Application ...
News, Short Squeeze, Breakout and More Instantly...
Rockwell Medical Inc. Company Name:
RMTI Stock Symbol:
NASDAQ Market:
Rockwell Medical Inc. Website:
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company's President and Chief Executive Officer, Dr. Mark Strobeck ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Tim Chole was promoted to Chief Commercial Officer, reporting to the ...